Biotech company Xihu OMI completes tens of millions of Yuan seed round financing


On March 1, Xihu OMI Biotechnology Co., Ltd. (hereinafter referred to as Xihu OMI) announced the completion of tens of millions of Yuan seed round financing. This round of financing is jointly led by Chende capital and Gaorong capital, and followed by hillhood venture capital. The financing will be used for talent recruitment, original technology breakthrough, clinical laboratory landing, R & D cooperation expansion, etc.
Founded in July 2020, the company is mainly engaged in the application of proteomics research in clinical auxiliary diagnosis. Specifically, the combination of proteomics big data and artificial intelligence, the digital technology of biological samples based on mass spectrometry, and the development of new clinical diagnosis methods based on proteomics and other molecular omics will help to realize the auxiliary diagnosis of tumor and other major diseases.